Thursday, 24 April 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 24 April 2025
Ascott/Nuevo
Ascott/Nuevo
$300M windfall for Aussie boss

This freshly-minted industry billionaire has has again sold down shares in Sigma Healthcare, netting himself a cool windfall.

How Pfizer CEO delighted the Pope
Ahead of the Pope's funeral this weekend, Pfizer boss Albert Bourla reveals the words that made the Pontiff's eyes light up
TODAY
Sanofi flashes blockbuster arsenal
Two of 2025's biggest names have made their first regulatory appearance in Australia, among six newcomers
TODAY
PiF jobs
PiF Jobs
KOLs earning most from pharma
New analysis reveals which HCPs have received the highest payments from pharma and which therapy areas attract most investment
23 April
Biologics to double COPD market
A new treatment paradigm supported by precision medicine will drive significant change in the market
23 April
Who's spending the most on HCPs?
Which company has retained its crown as the pharma with the highest spend on HCPs, according to the latest transparency data
22 April
Top earning CEO crown goes to...
Years of cumulative success has propelled a new CEO to the top of the highest-paid list. Find out who it is
22 April
Latest Jobs
PBS could become a 'brutal jungle'
What's at stake if Donald Trump resurrects international price referencing and what Aussie pharma execs should do about it
TODAY
Doctors snub pharma on AI
HCPs believe pharma could better leverage AI to support them but are skeptical about using the AI help that industry provides
TODAY
No promises on faster PBS listings
Debate between Health Minister Mark Butler and his Shadow Anne Ruston fails to secure timeline for faster medicines access
23 April
Sherlock Holmes takes on cancer
New Pfizer campaign uses famous stories to rewrite the narrative of a cancer diagnosis
23 April
Industry fails on patient-centricity
Fewer than one in five patients surveyed 'strongly agree' industry is patient-centric, prioritising their needs and preferences
23 April
RCA calls truce on PBAC bickering
Respected industry body expresses disappointment at both Government and industry for sniping that does nothing to help patients
22 April
Market boom to bypass Australia
New US clinical guidelines recommending earlier use of newer drugs will boost sales but Australia's unlikely to follow suit
22 April
J&J PBS candidate approved
Considered by PBAC last month, lung cancer treatment finally makes it onto the register with another long-awaited oncology product
22 April Approvals Action
Trump tosses pharma 'a crumb'
An executive order signed by the US President holds some good news for the pharma industry but analysts aren't impressed
17 April
Deal boosts pharma supply chain
Collaboration increases transparency and efficiency of supply chains for clinical trials in APAC
17 April
Hidden blocks hold women back
Industry coach unpacks the mindset blocks standing in the way of success for women pharma leaders
17 April
Why pharma can't sit on the fence
Industry executive warns Aussie pharma can't risk "sitting out" trade debates arguing: if you are not engaged, you are exposed
17 April
Drugs keeping Trump 'fighting fit'
US President undergoes his annual physical, revealing which drugs he takes to keep 'fully fit' as Commander-in-Chief
17 April
Rare AE for new cancer drug
Australian researchers reveal rare side effect for promising blood cancer drug about to be considered by the PBAC
16 April
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.